Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction. Early Post MI IV Dipyridamole Study (EPIDS).

Heller, G V; Brown, K A; Landin, R J; Haber, S B

Heller, G V; Brown, K A; Landin, R J; Haber, S B.

Affiliation

Heller GV; Nuclear Cardiology Laboratory, Memorial Hospital of Rhode Island, Brown University School of Medicine, Pawtucket, R.I., USA.

Am Heart J ; 134(1): 105-11, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9266790

Subject(s)

Coronary Circulation; Dipyridamole; Myocardial Infarction/diagnostic imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Angina, Unstable/etiology; Blood Pressure/drug effects; Death, Sudden, Cardiac/etiology; Electrocardiography; Female; Follow-Up Studies; Heart Rate/drug effects; Humans; Hyperemia/physiopathology; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction/classification; Myocardial Infarction/complications; Myocardial Infarction/physiopathology; Patient Discharge; Recurrence; Risk Assessment; Safety; Survival Rate

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Vasodilator Agents / Tomography, Emission-Computed, Single-Photon / Technetium Tc 99m Sestamibi / Radiopharmaceuticals / Coronary Circulation / Dipyridamole / Myocardial Infarction Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Year: 1997 Type: Article

Search on Google

XML

PubMed Links